Tenon Medical (TNON) Projected to Post Earnings on Tuesday

Tenon Medical (NASDAQ:TNON) is expected to post its Q1 2026 results after the market closes on Tuesday, May 12th. Analysts expect Tenon Medical to post earnings of ($0.3050) per share and revenue of $1.2960 million for the quarter. Individuals can find conference call details on the company’s upcoming Q1 2026 earning report page for the latest details on the call scheduled for Tuesday, May 12, 2026 at 4:30 PM ET.

Tenon Medical (NASDAQ:TNON) last announced its earnings results on Thursday, March 19th. The company reported ($0.22) EPS for the quarter, topping the consensus estimate of ($0.36) by $0.14. The business had revenue of $1.48 million for the quarter, compared to the consensus estimate of $1.38 million. Tenon Medical had a negative return on equity of 409.16% and a negative net margin of 318.36%.

Tenon Medical Price Performance

Shares of TNON traded up $0.00 on Tuesday, hitting $0.76. The company’s stock had a trading volume of 11,308 shares, compared to its average volume of 766,339. The company has a market capitalization of $8.55 million, a PE ratio of -0.38 and a beta of 1.28. Tenon Medical has a fifty-two week low of $0.64 and a fifty-two week high of $2.48. The company has a 50 day moving average price of $0.79 and a 200 day moving average price of $0.95.

Analysts Set New Price Targets

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Tenon Medical in a report on Monday, April 20th. One analyst has rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Tenon Medical currently has an average rating of “Hold”.

Institutional Trading of Tenon Medical

A number of large investors have recently made changes to their positions in TNON. Jane Street Group LLC bought a new stake in shares of Tenon Medical in the 1st quarter valued at $29,000. Geode Capital Management LLC increased its position in shares of Tenon Medical by 34.6% in the 4th quarter. Geode Capital Management LLC now owns 66,640 shares of the company’s stock valued at $63,000 after buying an additional 17,137 shares in the last quarter. Finally, DRW Securities LLC bought a new stake in shares of Tenon Medical in the 4th quarter valued at $98,000. Institutional investors own 22.74% of the company’s stock.

About Tenon Medical

Tenon Medical, Inc is a development-stage medical device company focused on the research, development and commercialization of next-generation surgical biologic adhesives and sealants. The company’s proprietary platform is designed to create tissue-compatible adhesives that can serve as alternatives or complements to traditional sutures and staples, with the goal of improving surgical efficiency, reducing postoperative complications and enhancing patient outcomes.

Tenon Medical’s product pipeline centers on protein-based polymer formulations that cross-link in situ to form a flexible, yet durable, bond with native tissue.